Register for access to the platform
We ask a few short questions about your expected use of our technology to make sure it is a fit with what we can reliably deliver.
For Physicians
Turn "no options" into next steps for your patients.
If you want to treat more rare disease patients, Nome is for you.
Why Nome for clinicians
Personalized therapies present exciting new possibilities for your patients. However, the work of assessing which patients can benefit is complicated and outside of traditional clinical workflows.
Nome does the work of synthesizing information about the patient in front of you to help you determine if a custom personalized therapy might be appropriate. If you and your patient are interested in developing a therapy, we do all the hard work of designing, testing, manufacturing, and receiving regulatory and institutional approval to treat your patient.
About Togo — Our AI Platform
Minutes, not weeks.
Togo reads a patient's genetic variant and disease context, then searches published literature, active clinical trials, therapeutic platforms, and real-world case data. It synthesizes everything into a prioritized amenability assessment with cited evidence — in minutes, where a PhD-level expert would need weeks.
97% precision — benchmarked against a curated library of known variants. Every report is validated by a PhD scientist before it reaches a patient or clinician.
Sample Report Output
Modality
Amenability
Confidence
Status
ASO (Exon Skipping)
87
High
Actionable
Clinical Trial Match
78
High
Actionable
Gene Therapy (AAV)
62
Moderate
Evaluate Further
Base Editing (ABE)
41
Moderate
Evaluate Further
Drug Repurposing
23
Low
Low Feasibility
Each patient receives a scored assessment across all viable therapeutic modalities for their specific mutation.
How Nome Works For Providers
Three steps from registration to rationale.
-
-
Provide genetic test results
We are HIPAA-compliant and our Business Associate Agreement can be found here. We take protecting patient privacy seriously.
-
Review summary & go deeper
Our technology delivers a concise Provider Brief: a prioritized set of options with mechanism-level rationale and citations. Using our chat-interface, you can interrogate how we arrived at our assessment and dive into the data. Transparency is built into our DNA.
Provider FAQs
Questions clinicians ask first.
How is this different from a literature search?
Search takes a long time and just lists information. Nome maps patient-specific options and provides the steps to act.
Do you make treatment recommendations?
No. We present options with evidence and feasibility. You make all care decisions.
What evidence do you use?
Peer-reviewed studies, registries, case reports, mechanistic data, and current trial and program information—synthesized for one patient. We cite every source we use to generate reports in-line and have a literature review and logic interrogation option built into our tool for your understanding of how recommendations are made. Reach out to us to learn more.
How does this fit into clinical workflows?
You can provide this information to patients as they are diagnosed or their prognosis changes and searching for additional options makes sense. We are here to provide insights when your patients need them. We have the ability to return our results via Genetic Counselors and MDs we partner with - reach out to ask us about how to enable this service for your clinic.
